AFFINI-T

Serial Number 97322827
Registration 7764869
700

Registration Progress

Application Filed
Mar 21, 2022
Under Examination
Approved for Publication
Mar 4, 2025
Published for Opposition
Mar 4, 2025
Registered
Apr 22, 2025

Trademark Image

AFFINI-T

Basic Information

Serial Number
97322827
Registration Number
7764869
Filing Date
March 21, 2022
Registration Date
April 22, 2025
Published for Opposition
March 4, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 22, 2025
Registration
Registered
Classes
005

Rights Holder

Affini-T Therapeutics, Inc.

03
Address
343 Arsenal St.
Watertown, MA 02472

Ownership History

Affini-T Therapeutics, Inc.

Original Applicant
03
Watertown, MA

Affini-T Therapeutics, Inc.

Owner at Publication
03
Watertown, MA

Affini-T Therapeutics, Inc.

Original Registrant
03
Watertown, MA

Legal Representation

Attorney
Theodore J. Bielen, Jr.

USPTO Deadlines

Next Deadline
1907 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250422)
Due Date
April 22, 2031
Grace Period Ends
October 22, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

20 events
Date Code Type Description Documents
Apr 22, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Apr 22, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 4, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 4, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 26, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 8, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 17, 2024 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Nov 21, 2023 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Nov 21, 2023 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Nov 21, 2023 CNSL R SUSPENSION LETTER WRITTEN Loading...
Oct 18, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 17, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 17, 2023 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Jul 3, 2023 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Dec 31, 2022 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Dec 31, 2022 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Dec 31, 2022 CNSL R SUSPENSION LETTER WRITTEN Loading...
Dec 31, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 25, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 24, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Biological preparations for the treatment of cancer; Chemical reagents for medical purposes ,all of the foregoing in the field of analysis and treatment of multiple tumor associated antigens utilizing immune cells
First Use Anywhere: Mar 1, 2022
First Use in Commerce: Mar 1, 2022

Classification

International Classes
005